COVID-19 messenger ribonucleic acid vaccination and abnormal radiopharmaceutical uptake in the axilla visualized on (68)Ga-DOTATATE positron-emission tomography/computed tomography

As COVID-19 vaccination rates continue to rise, it is becoming increasingly important to understand diagnostic imaging associations’ resultant from the vaccines. Here, we report a case of a 59-year-old female who was in remission for gastrointestinal neuroendocrine carcinoma and presented for standa...

Descripción completa

Detalles Bibliográficos
Autores principales: Weissman, Joshua Philip, Bartel, Twyla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686744/
https://www.ncbi.nlm.nih.gov/pubmed/35018159
http://dx.doi.org/10.4103/wjnm.wjnm_54_21
Descripción
Sumario:As COVID-19 vaccination rates continue to rise, it is becoming increasingly important to understand diagnostic imaging associations’ resultant from the vaccines. Here, we report a case of a 59-year-old female who was in remission for gastrointestinal neuroendocrine carcinoma and presented for standard follow-up imaging evaluation. Positron-emission tomography (PET) images from a (68)Ga-DOTATATE PET (NETSPOT) demonstrated moderate focal radiotracer uptake in the right axilla. Interestingly, this uptake localized to several normal-sized lymph nodes on the corresponding computed tomography (CT). A medical history revealed the patient received both doses of an ipsilateral COVID-19 messenger ribonucleic acid vaccine injection at 17 and 38 days before the PET/CT study. Subsequent scans 2 months later revealed no radiotracer uptake.

Ejemplares similares